The first phase of reopening has allowed clinicians to begin routine care and perform postponed procedures—yet the threat of infection remains. CMS' Opening Up America Again: Re-opening Facilities to Provide Non-emergent Non-COVID-19 Healthcare: Phase I instructs practices to be vigilant not only to test patients and staff for COVID-19, but also to be aware of the rate of incidence in their region and prepare to cease non-essential procedures if a surge emerges.
"COVID-19 testing" can refer to a handful of different procedures, depending on what you're testing for, how the test is administered, and when (how long after symptoms are discovered) the test is administered. The tests fall under three categories, each independently valuable: molecular, antigen, and antibody.
In collaboration with our diagnostic partners, we offer a wide array of diagnostics specific to COVID-19. For additional information about our COVID-19 test portfolio, contact your Henry Schein Medical Representative or fill out the form above.